HEART2SAVE WAS FOUNDED FOR A GOOD REASON

”The long experience as an Emergency doctor urged me to search for new and better ways for diagnosing symptomless arrhythmia before a more serious, possibly fatal stroke. Only a few of us have an opportunity to undergo frequent ECG screening in hospital environment. However, if a proactive screening based on continuous heart rate monitoring could be implemented among the risk groups, the impact could be economically significant. Most importantly, individual suffering could be avoided”

Cardiac arrhythmia can be harmless or in the other end of the spectrum, fatal. The most common long-term cardiac arrhythmia is atrial fibrillation (AF). It is the nasty one, because for some patients it causes symptoms, but many remain completely symptomless.

Regardless of the symptoms, the danger of atrial fibrillation is its increase in the risk of stroke casing 25% of the strokes. In fact, the first symptom of AF can be a large stroke with hemiplegia. Provided the atrial fibrillation is diagnosed before the stroke and proper anticoagulation therapy is initiated, approximately two thirds of AF-related strokes can be prevented.

Heart2Save solution is based on the arrhythmia detection algorithm which enables easy diagnosis of a latent arrhythmia by health care professionals in many different environments like in nursing homes. It can also be used by risk groups or by anyone who wants to follow your heart as part of your daily lives and exercise program.

An artificial intelligence (AI) based analytics program developed by Heart2Save can very reliably diagnose heart arrhythmia, for example, by using sensors attached to a mobile phone. The underlying algorithm for atrial fibrillation detection is currently in the medical validation and licensing process based on the ECG data collected from more than 4000 patients.

Also a continuous-use heart rate monitor, such as a sport or smart watch based on optical pulse measurement, can be used to alert of the need for more accurate measurement. Heart2Save has created an end-to-end solution where measurement results are sent to a cloud service for analysis and further on to a medical reporting system.

The ideal system will consist of wearables as a warning device, mobile-ECG as a diagnostic device and transmission of arrhythmia ECG into doctor for individualized care.

Latest news

When is the right time for a start-up to start sponsoring an athlete? Strong positive cash flow/market position? We desided NOW, in the middle of product developement. Heart2Save proudly support, follow and secure the route of Finnish rower Joel Naukkarinen

Combined Annual Meeting of the Finnish Society for Medical Physics and Medical Engineering and BIOMEP doctoral programme 8-9.2.2019 in Tahko Golden resort. The head of our algorithms PhD Mika Tarvainen gives a presentation. “Physiological monitoring – from research to busin

Preparations for the first clinical evaluations have started and several new frame agreements are under negotiations. Please contact us if you are interested to participate.
Company’s financing round collected new investors completing the team with new talent and enabling so